AVE1231 (A293) is a dual-pore potassium channel TASK-1 inhibitor with antiarrthmic activity[1].
References:
[1]. Wiedmann F, et al. Identification of the A293 (AVE1231) binding site in the cardiac two-pore-domain potassium channel TASK-1: a common low affinity antiarrthmic drug binding site[J]. Cellular Psiology & Biochemistry (Cell Psiol Biochem Press GmbH & Co. KG), 2019, 52(5).
















